Additionally, quercitrin has shown a decrease in proinflammatory and proatherogenic vascular endothelial growth factors (VEGF) at a dose of 10 μmol/L blocking VEGF expression upregulated by Cu2+-oxidized-low-density lipoprotein (Cu2+-oxLDL) in J774A1 mouse histiocytic lymphoma cells [26]. The gene discussed is VEGFA; the disease is reticulum cell sarcoma.